Citations 1
Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections
Orenstein, Robert , Hecht, Gail , Tillotson, Glenn S. , Khanna, Sahil , Harvey, Adam
Open Forum Infectious Diseases | September 8, 2023 | Volume: 10 | Issue: 9 | Pages: No page available
